Home > Press > UCLA researchers use nanoparticles to send chemotherapy drug directly to the tumor site, reducing damage to healthy tissues
Tunde Akinloye for CNSI Huan Meng, Dr. Andre Nel and Xiangsheng Liu |
Abstract:
The overall five-year survival rate for people with pancreatic cancer is just 6 percent, and there is an urgent need for new treatment options. More than 80 percent of pancreatic cancer diagnoses occur too late for surgery, making chemotherapy the only possible treatment.
Scientists from the California NanoSystems Institute at UCLA and UCLA’s Jonsson Comprehensive Cancer Center have developed a delivery system for one chemotherapy drug that greatly reduces the occurrence of serious side effects while enhancing the drug’s effectiveness against pancreatic cancer. The approach uses mesoporous silica nanoparticles to deliver the drug directly to the tumor instead of having the free drug spread throughout the body via the bloodstream.
The study was led by Dr. Andre Nel, associate director of the California NanoSystems Institute, and Huan Meng, an assistant professor of nanomedicine; it was published in the journal ACS Nano. Xiangsheng Liu, a postdoctoral scholar in the UC Center for Environmental Implications of Nanotechnology, was the study’s first author.
In recent years, the chemotherapy regimen known as FOLFORINOX, which combines the drugs 5-fluorouracil, irinotecan, oxaliplatin and leucovorin, has improved survival outcomes over the standard treatment option, gemcitabine, which has fewer side effects. The severe side effects of FOLFORINOX, which are primarily caused by the irinotecan component, mean that only a minority of the healthiest patients can be treated with it.
The silica nanoparticles used in the study work like glass bubbles that contain a large amount of irinotecan in pores on their surfaces. The particles are wrapped in a double layer of lipids, similar to cell membranes, which safely trap the drug without leakage until the nanoparticle reaches the cancer site, where it is designed to unload the drug based on the acidic environment of the cancer cell.
“Because of stable drug retention by the lipid layers, the nanoparticles greatly reduce the amount of healthy tissue cells exposed to irinotecan,” Nel said. “The severe side effects of irinotecan largely result from its exposure to healthy tissues such as bone marrow, liver, and gut.”
The researchers compared the effectiveness of the lipid-coated nanoparticles to an FDA-approved irinotecan carrier that encases drug molecules in fatty spherical particles called liposomes. In mice with human pancreatic tumors, delivering the drug via silica nanoparticles reduced tumor size more effectively than delivering it via liposomes. The nanoparticle technique was also safer because less of the drug leaked into the bloodstream.
“This dramatically decreased the amount of severe side effects to the bone marrow, gastrointestinal tract and liver in the mice. The nanoparticles were also more efficient than the liposomes in treating the spread of tumors to surrounding organs,” Liu said.
The researchers believe that a FOLFORINOX regimen could be made safer and more effective against pancreatic cancer using the mesoporous silica nanoparticle delivery system for irinotecan, Meng said. He added that they still have some distance to go before launching a human clinical trial, but with this study they have developed a normal strategy for irinotecan delivery by a nanoparticle. Their technique would make it relatively easy to scale up the technology to production levels, because the nanoparticles’ effectiveness means that less of the drug is required for treatment.
The researchers also found that their approach can be used to deliver several other chemotherapy drugs, meaning that it may also prove useful in treating other types of cancer.
Support for this research was provided by the U.S. Public Health Service and the Hirschberg Foundation for Pancreatic Cancer Research. The research utilized the Core Technology Centers at the California NanoSystems Institute.
####
For more information, please click here
Contacts:
Shaun Mason, CNSI
310-794-5346
Copyright © UCLA
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Cancer
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Super-efficient laser light-induced detection of cancer cell-derived nanoparticles: Skipping ultracentrifugation, detection time reduced from hours to minutes! October 6th, 2023
Govt.-Legislation/Regulation/Funding/Policy
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Chemical reactions can scramble quantum information as well as black holes April 5th, 2024
Possible Futures
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
With VECSELs towards the quantum internet Fraunhofer: IAF achieves record output power with VECSEL for quantum frequency converters April 5th, 2024
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Discoveries
Chemical reactions can scramble quantum information as well as black holes April 5th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Utilizing palladium for addressing contact issues of buried oxide thin film transistors April 5th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Nanobiotechnology
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||